These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17918023)

  • 1. Behavioral strategies to improve treatment participation and retention by pregnant drug-dependent women.
    Svikis DS; Silverman K; Haug NA; Stitzer M; Keyser-Marcus L
    Subst Use Misuse; 2007; 42(10):1527-35. PubMed ID: 17918023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral contingencies improve counseling attendance in an adaptive treatment model.
    Brooner RK; Kidorf MS; King VL; Stoller KB; Peirce JM; Bigelow GE; Kolodner K
    J Subst Abuse Treat; 2004 Oct; 27(3):223-32. PubMed ID: 15501375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a low-cost incentive intervention to improve counseling attendance among methadone-maintained patients.
    Sigmon SC; Stitzer ML
    J Subst Abuse Treat; 2005 Dec; 29(4):253-8. PubMed ID: 16311177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does dialectical behavior therapy facilitate treatment retention among individuals with comorbid borderline personality disorder and substance use disorders?
    Bornovalova MA; Daughters SB
    Clin Psychol Rev; 2007 Dec; 27(8):923-43. PubMed ID: 17376574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking stage of change is associated with retention in a smoke-free residential drug treatment program for women.
    Haller DL; Miles DR; Cropsey KL
    Addict Behav; 2004 Aug; 29(6):1265-70. PubMed ID: 15236833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between low-magnitude voucher and buprenorphine medication contingencies in promoting abstinence from opioids and cocaine.
    Gross A; Marsch LA; Badger GJ; Bickel WK
    Exp Clin Psychopharmacol; 2006 May; 14(2):148-56. PubMed ID: 16756418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining behavioral and self-help approaches in the inpatient management of dually diagnosed patients.
    Franco H; Galanter M; Castañeda R; Patterson J
    J Subst Abuse Treat; 1995; 12(3):227-32. PubMed ID: 7474031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of abstinence-based incentives: interaction with intake stimulant test results.
    Stitzer ML; Petry N; Peirce J; Kirby K; Killeen T; Roll J; Hamilton J; Stabile PQ; Sterling R; Brown C; Kolodner K; Li R
    J Consult Clin Psychol; 2007 Oct; 75(5):805-11. PubMed ID: 17907862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
    Nunes EV; Rothenberg JL; Sullivan MA; Carpenter KM; Kleber HD
    Am J Drug Alcohol Abuse; 2006; 32(4):503-17. PubMed ID: 17127538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying pregnant women at risk for early attrition from substance abuse treatment.
    Kissin WB; Svikis DS; Moylan P; Haug NA; Stitzer ML
    J Subst Abuse Treat; 2004 Jul; 27(1):31-8. PubMed ID: 15223091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What if they do not want treatment?: lessons learned from intervention studies of non-treatment-seeking, drug-using pregnant women.
    Jones HE; Svikis D; Rosado J; Tuten M; Kulstad JL
    Am J Addict; 2004; 13(4):342-57. PubMed ID: 15370933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community reinforcement therapy for cocaine-dependent outpatients.
    Higgins ST; Sigmon SC; Wong CJ; Heil SH; Badger GJ; Donham R; Dantona RL; Anthony S
    Arch Gen Psychiatry; 2003 Oct; 60(10):1043-52. PubMed ID: 14557150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abstinence incentive effects in a short-term outpatient detoxification program.
    Katz EC; Chutuape MA; Jones H; Jasinski D; Fingerhood M; Stitzer M
    Exp Clin Psychopharmacol; 2004 Nov; 12(4):262-8. PubMed ID: 15571443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A contingency analysis of family treatment and drug abuse.
    Todd TC
    NIDA Res Monogr; 1984; 46():104-14. PubMed ID: 6427618
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients.
    Higgins ST; Heil SH; Dantona R; Donham R; Matthews M; Badger GJ
    Addiction; 2007 Feb; 102(2):271-81. PubMed ID: 17222282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use of disorders in HIV-infected patients: impact and new treatment strategies.
    Fiellin DA
    Top HIV Med; 2004; 12(3):77-82. PubMed ID: 15310938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving treatment outcomes for pregnant drug-dependent women using low-magnitude voucher incentives.
    Jones HE; Haug NA; Stitzer ML; Svikis DS
    Addict Behav; 2000; 25(2):263-7. PubMed ID: 10795950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal evaluation of treatment engagement and recovery stages.
    Simpson DD; Joe GW
    J Subst Abuse Treat; 2004 Sep; 27(2):89-97. PubMed ID: 15450643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Admission variables as predictors of completion in an adolescent residential drug treatment program.
    Vourakis C
    J Child Adolesc Psychiatr Nurs; 2005; 18(4):161-70. PubMed ID: 16236098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.